期刊文献+

高效液相-质谱联用测定阿奇霉素的血浆浓度 被引量:1

Determination of azithromycin in human plasma by liquid chromatography mass spectrometry
下载PDF
导出
摘要 目的:本实验建立了高效液相-质谱联用(HPLC-MS/MS)法测定正常人血浆中的阿奇霉素浓度。方法:血浆中加入罗红霉素作为内标,以碱化的醋酸乙酯提取,进行HPLC-MS/MS的测定。采用Hanbon Lichrospher C18柱(2.1mm×100mm,5μm),柱温30℃,流动相为乙睛-醋酸铵缓冲液(0.2%醋酸+0.1%醋酸铵溶液)(60∶40),流速0.25mL·min-1;质谱采用选择性离子检测方法。结果:阿奇霉素的线性范围为1.0~1000mg·L-1,最低检测质量浓度为1.0μg·L-1。回收率及精密度的测定均符合生物样品分析的要求。结论:该方法操作简便,灵敏度高,专属性强,可用于测定阿齐霉素的血药浓度。 ORJECTIVE To established an HPLC MS/MS method to determine of azithromycin in human plasma, for pharmacokinetic study. METHODS The drug was extracted by diethyl ether from human plasma with the clarithromycin as internal standard. The evaporated samples were dissolved in mobile phase and separated by Hanbon Lichrospher C18 (100 mm × 2. 1 mm, 5/am) column. The eluate from the ttPLC column was plumbed directly into ESI probe with the mobile phase containing (0. 1% ammonium acetate-0. 2% acetonitrile)-acetonitrile (40:60) at flow rate of 0. 25 mL.min-1. Analysis in the mass spec- trometer was operated in the selection monitoring mode. RESULTS The method demonstrated that good linearity ranged from 1 to l 000μg.L-1. The limit of quantification for azithromycin in plasma was μg.L-1 with good accuracy and precision, and so was the extraction recovery. CONCLUSION The method has been successfully applised to the bioequivalence study of azithro- mycin for 20 healthy human plasma.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第18期1556-1559,共4页 Chinese Journal of Hospital Pharmacy
关键词 阿奇霉素 血浆浓度 高效液相一质谱联用法 azithromycin drug concentration HPLC-MS/MS
  • 相关文献

参考文献7

  • 1陈炜,来彩霞,刘党生,谢玉香,刘桂清,李祝华.阿奇霉素分散片的人体相对生物利用度[J].沈阳药科大学学报,2000,17(5):316-317. 被引量:12
  • 2王玉花,陈俊杰,陈本美,张毕奎.液质联用测定血浆中阿奇霉素及其人体药动学和相对生物利用度研究[J].中国药学杂志,2006,41(1):51-54. 被引量:14
  • 3Najib NM, Idkaidek N,Ghanem IE, et al. Bioequivalenee assessment of azomycin (Julphar, UAE) as compared to zithromax fizer, USA. 2twobrands of azithromycin2in healthy human volunteers[J]. Biopharm Drug Dispos,2001,22(1) :15.
  • 4Fouda HG, Schneider RP. Quantitative determination of the antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with a standard HPLC-electrochemical method[J]. Ther Drug Monit, 1995, 17 (2) : 179.
  • 5赵恒利,崔晞,王本杰,卜凡龙,郭瑞臣.HPLC-MS法研究阿奇霉素片剂与胶囊的人体相对生物利用度及药代动力学[J].药物分析杂志,2006,26(3):304-307. 被引量:3
  • 6Shah VP, Midha KK, Dighe S, et al. Analytical methods validation., bioavailability, bioavailability, bioequivalence and pharmacokinetic studies[J]. Pharm Sci, 1992,81:309.
  • 7Lingyun Chen, Feng Qin, Yuanyuan Ma, et al. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-eleetrospray ionization mass spectrometry and its application in a pharmacokinetic study [J]. Journal of Chromatography B, 2007,855: 255-261.

二级参考文献10

共引文献25

同被引文献13

  • 1Akaike H, Miyashita N, Kubo M, et al. In vitro activities of 11 antimicrobial agents against macrolideresistant Mycoplas- ma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study [J]. Jpn J Infect Dis, 2012, 65 (6) : 535-538.
  • 2Shah SS, Test M, Sheffler-Collins S, etal. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia [J]. J Hosp Med, 2012, 7(4):311-317.
  • 3Pientong C, Ekalaksananan T, Teeratakulpisarn J, et al. A- typical bacterial pathogen infection in children with acute bron- chiolitis in northeast Thailand [J]. J Mierohiol Immunol In- fect, 2011, 44(2) :95-100.
  • 4Christie J. Diagnosing Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia[J]. Am J Nurs, 2013, 113(5):65-65.
  • 5Ma HM, Ip M, Hui E, et al. Role of atypical pathogens in nursing home-acquired pneumonia [J]. J Am Med Dir Assoc, 2013, 14(2):109-113. W.
  • 6aites KB, Dully LB, B6b6ar CM, et al. Standardized meth- ods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum [J]. J Clin Microbiol, 2012, 50(11) :3542-3547.
  • 7Remmelts HH, Meijvis SC, Biesma DH, et al. Dexametha- sone downregulates the systemic eytokine response in patients with community-acquired pneumonia [J]. Clin Vaccine Immu- nol, 2012, 19(9):1532- 1538.
  • 8Sφarensen CM, Schonning K, Rosenfeldt V. Clinical character- istics of children with Mycoplasma pneumoniae infection hospi- talized during the Danish 2010- 2012 epidemic [J]. Dan Med J, 2013, 60(5):A4632.
  • 9Shah SS, Test M, Sheffler-Collins S, etal. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia [J]. J Hosp Med, 2012, 7(4): 311-317.
  • 10Lee PI, Wu MH, Huang LM, et al. An open, randomized, comparative study of clarithromyein and erythromycin in the treatment of children with community-acquired pneumonia [J]. J Microhiol Immunol Infect, 2008, 41 (1) : 54-61.

引证文献1

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部